💰 Financial Performance

Revenue Growth by Segment

Consolidated revenue grew 44% YoY to INR 1,196 Cr in FY24, followed by 27.4% growth to INR 1,524 Cr in FY25. Growth is primarily driven by the Aerospace and Defense segments, which saw strong order execution. H1 FY24 revenue specifically grew 50% YoY to INR 509 Cr.

Geographic Revenue Split

The United States contributes approximately 25% of total revenue (excluding the Altek facility). The company also serves clients in Europe, North America, India, China, and Japan.

Profitability Margins

PAT margin was 5.1% in FY24 (INR 61 Cr) and moderated to 3.6% in FY25 (INR 68 Cr). Normalized PAT margin in Q2 FY26 was reported at 4%, though reported PAT was higher at 10.3% due to a one-time gain from performance conditions not being met in the Altek acquisition.

EBITDA Margin

EBITDA margin was 9.3% in FY24, a decrease from 11-12% in FY23. Q1 FY25 margin was 7.8%. The moderation is attributed to a substantial increase in employee headcount, ESOP expenses, and the delivery of a large low-margin order. The company targets a return to double-digit margins (10-11%) through better fixed cost absorption.

Capital Expenditure

The company utilized INR 700 Cr from IPO proceeds for debt repayment, working capital, and capital investments. The acquisition of Altek Electronics Inc was valued at approximately INR 248 Cr ($29.2 million), funded through INR 103 Cr of foreign exchange debt, INR 70 Cr from IPO proceeds, and internal accruals.

Credit Rating & Borrowing

CRISIL A+/Positive for un-guaranteed facilities and CRISIL AA/Stable for facilities guaranteed by Cyient Ltd. The company maintains a net external debt-free status post-IPO, utilizing low-cost foreign exchange debt for acquisitions.

⚙️ Operational Drivers

Raw Materials

Specific materials include printed circuit boards (PCBs), electronic components, and subsystems for high-tech engineering, representing the bulk of the manufacturing cost base.

Import Sources

Sourced globally to support manufacturing units in India and the United States (via Altek facility in Connecticut).

Key Suppliers

Not specifically named in available documents; however, the company operates as a partner to major OEMs in Aerospace, Defense, and Medical sectors.

Capacity Expansion

Current capacity supports an order book of INR 2,127 Cr as of June 2024. Expansion is driven by the Altek acquisition in the US and enhanced hiring in FY24 to cater to medium-term demand.

Raw Material Costs

Raw material costs are susceptible to price fluctuations; the company manages this through an ongoing shift to higher-margin orders and benefits of operating leverage as scale increases.

Manufacturing Efficiency

Efficiency is driven by the 'design-led manufacturing' model, which integrates Cyient Ltd's engineering designs into production, improving fixed cost absorption as revenue scales toward INR 1,500 Cr+.

📈 Strategic Growth

Expected Growth Rate

30-40%

Growth Strategy

Growth will be achieved through the execution of a healthy order book (INR 2,127 Cr as of June 2024), the full-year integration of Altek Electronics (which contributed INR 174.66 Cr in FY25), and expanding the 'design-to-production' synergy with parent company Cyient Ltd. The company is focusing on high-margin export orders and new product mass manufacturing.

Products & Services

System design, integration, testing, and manufacturing of electronic components, subsystems, and printed circuit board assemblies (PCBA) for Aerospace, Defense, Medical, and Industrial OEMs.

Brand Portfolio

Cyient DLM.

New Products/Services

Expansion into the semiconductor business and complete engineering solutions (design-to-production) in collaboration with Cyient Ltd.

Market Expansion

Aggressive expansion into the US market via the Altek acquisition and increasing domestic sales in India driven by defense sector demand.

Market Share & Ranking

Not disclosed in available documents, but described as a 'moderate scale' player with revenues under INR 1,500 Cr.

Strategic Alliances

Strong parental support from Cyient Ltd, which holds a 52.12% stake as of June 2025 and provides managerial and financial backing.

🌍 External Factors

Industry Trends

The EMS (Electronic Manufacturing Services) industry is seeing a shift toward design-integrated manufacturing. Cyient DLM is positioning itself to provide end-to-end solutions rather than just assembly, moving from 15% historical growth to 30-40% projected growth.

Competitive Landscape

Competes with other Tier-II IT and EMS providers; market dynamics are currently impacted by industry-wide stock price volatility (38.6% dip in early 2025).

Competitive Moat

The primary moat is the synergy with Cyient Ltd's Engineering Research and Development (ER&D) services, allowing for a 'design-to-production' value proposition that is difficult for pure-play EMS providers to replicate.

Macro Economic Sensitivity

Sensitive to global aerospace and defense spending and US trade policies/tariffs.

Consumer Behavior

Shift in OEM behavior toward seeking partners who can handle both design and manufacturing to reduce supply chain complexity.

Geopolitical Risks

Exposure to US-China trade tensions; mitigated by acquiring a local US manufacturing unit (Altek) to handle US-based demand.

⚖️ Regulatory & Governance

Industry Regulations

Subject to stringent Aerospace and Defense manufacturing standards and US import/export tariffs which are currently a key monitorable.

Legal Contingencies

Goodwill of INR 63.84 Cr from acquisitions is being amortized over five years starting FY25. No specific pending court cases with values were disclosed.

⚠️ Risk Analysis

Key Uncertainties

Potential for 20-30% margin volatility if product mix shifts back to low-margin orders or if employee costs continue to rise faster than fixed cost absorption.

Geographic Concentration Risk

Significant exposure to the US market (25% direct + Altek facility).

Third Party Dependencies

High dependency on parent Cyient Ltd for design leads and financial guarantees (though some guarantees were recently waived).

Technology Obsolescence Risk

Risk is mitigated by the company's involvement in high-tech sectors (Semiconductors, A&D) and its integration with Cyient's ER&D capabilities.

Credit & Counterparty Risk

Receivables quality is generally high given the strong credit profiles of global OEM clients in A&D and Medical sectors.